Pneumostem®

BIOLOGICAL5 trials

Sponsors

Samsung Medical Center, Medipost Co Ltd.

Conditions

BPDBronchopulmonary DysplasiaPremature InfantsPulmonary Arterial Hypertension (PAH)

Phase 1

PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension

Not yet recruitingNCT07368088

Samsung Medical CenterPremature Infants, Pulmonary Arterial Hypertension (PAH)

Start: 2026-03-01End: 2027-07-01Target: 12Updated: 2026-01-26

Phase 2

Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants

CompletedNCT01828957

Medipost Co Ltd.Bronchopulmonary Dysplasia

Start: 2013-04-30End: 2015-08-31Updated: 2019-09-06

Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

Active, not recruitingNCT04003857

Medipost Co Ltd.BPD, Bronchopulmonary Dysplasia

Start: 2019-07-05End: 2027-06-30Target: 60Updated: 2025-02-07

Unknown Phase

Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia

Active, not recruitingNCT01632475

Samsung Medical CenterBronchopulmonary Dysplasia

Start: 2011-09-30End: 2026-09-30Updated: 2019-04-09

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial

CompletedNCT01897987

Medipost Co Ltd.Bronchopulmonary Dysplasia

Start: 2014-01-31End: 2020-03-31Updated: 2020-08-07

Related Papers

Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia

Thorax2023-08-2111 citations

Stem Cells for Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Controlled Phase II Trial

Stem Cells Translational Medicine2021-04-20104 citations

Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia

The Journal of Pediatrics2017-03-21214 citations